Abstract

Research Article

Use of Orthodeoxia by pulse Oximetry in the detection of Hepatopulmonary Syndrome

Cesar Raul Aguilar Garcia* and Guadalupe Viridiana Ontiveros Guerra

Published: 04 August, 2017 | Volume 1 - Issue 1 | Pages: 038-041

Chronic Hepatic deficiency due to the ingestion of alcohol remains as one of the main causes of morbidity and mortality in our country. From it a variety of complications arise, one of them is the Hepatopulmonary Syndrome, which usually goes unnoticed and undiagnosed; this syndrome is distinguished by the presence of hypoxemia and pulmonary vasodilation. The gold standard to establish a diagnostic is contrast-enhanced Echocardiogram. No pathognomonic sign is known for this syndrome, which leads the present elaboration to evaluate the use of orthodeoxia by pulse oximetry as a screening test in the detection of Hepatopulmonary Syndrome cases. 

Read Full Article HTML DOI: 10.29328/journal.ascr.1001005 Cite this Article Read Full Article PDF

Keywords:

Orthodeoxia; Hepatic Deficiency; Pulmonary vasodilatation

References

  1. Salazar-Marcelino AE, Herrera-García JC, Toledo-Estrada J, Mendoza-Torres MA, Romero- Ogawa T. Síndrome Hepatopulmonar: Situación clínica en un hospital de tercer nivel en Puebla, Mexico. Neumólogo Cir Tórax. 2016; 75: 18-24. Ref.: https://goo.gl/41PTHu
  2. Nacif LS, Andraus W, Pinheiro RS, Ducatti L, Haddad LB, et al. The hepatopulmonary syndrome. Arq Bras Cir Dig. 2014; 27: 145-147. Ref.: https://goo.gl/wT8WE5
  3. Muñoz JG. Síndrome hepatopulmonar. Rev Med Cos Cen. 2014; 71: 395-401. Ref.: https://goo.gl/cHUySF
  4. Raevens S, Geerts A, Van Satenkiste C, Verhelest X, Van Vlerberghe H, et al. Hepatopulmonary syndrome and portopulmonary hipertensión: reventar knowtedege in pathogenesis and overview of clinical assessment. Liver Int. 2015; 35: 1646-1660. Ref.: https://goo.gl/U8xc7Q
  5. Sáenz-Gómez J, Karam- Bechara J, Jamaica-Banderas L. Síndrome hepatopulmonar como causa de hipoxemia en niños con enfermedad hepática. Bol Med Hospital Infantil Mex. 2015; 72: 124-128. Ref.: https://goo.gl/yWgbdd
  6. Muñoz-Maya OG, Santos OM, Granda P, Vega J, Martin JI, et al. Síndrome hepatopulmonar en paciente con hipertensión portal no cirrotica. Reporte de caso. Rev Col Gastroenterol. 2012; 27: 323-326. Ref.: https://goo.gl/1XD8DL
  7. Orozco-Delgado M, López-Cantero M, Zampe, la V, Vicente R, Galan J. Factores predicadores de mortalidad y estrategias de detección precoz de síndrome hepatopulmonar en pacientes transpalntados hepáticos. Predictors of mortality and early detection strategies for hepatopulmonary syndrome in liver transplant patients. Rev Colombia Anestesiol. 2016; 44: 311-316. Ref.: https://goo.gl/hyFDde
  8. Lyer VN, Swanson KI, Cartín CR, Dierkhising RA, Rosen CB, et al. Hepatopulmonary syndrome: favorable outcomes ni the MELD exception Era. Hepatology jun. 2013; 57: 2427-2435. Ref.: https://goo.gl/PZXk5A
  9. Carrillo ER, Gonzalez SJ, Serralde ZA. Síndrome Hepatopulmonar. Rev Fac Med. 2001; 44: 207-211.
  10. Navasa M, Agusti C. Síndrome Hepatopulmonar. Asociación Española de Estudios del Higado.
  11. Lange PA, Stoller KJ. The Hepatopulmonary Syndrome. Ann Intern Med. 1995; 122: 521-29. Ref.: https://goo.gl/6iAwuo
  12. Grace JA, Angus PW. Hepatopulmonary syndrome: update on recent advances in phatophysiology, invetigation, and treatment. J Gastroenterol Hepatol. 2013; 28: 213-219. Ref.: https://goo.gl/bw9oYk
  13. Rabiller A, Núñez H, Lebrec D, Tazl KA, Wartski M, et al. Prevention os gram-negative translocation reduces the severidad oh hepatopulmonary syndrome. Am J Respir Crit Care Med. 2002; 66: 514-517. Ref.: https://goo.gl/Yj5uhG
  14. Ahad E, Amir AK, Seung KA. Pharmacologivsl treatment for hepatopulmonary syndrome. Bío Med Research International. 2013. Ref.: https://goo.gl/DbA2yB

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?